Tag archive for ‘Anne White’
By pharmanewsdaily On Wednesday, August 19th, 2020

Lilly, Innovent Biologics expand licensing deal for blood cancer drug Tyvyt

(adsbygoogle = window.adsbygoogle || []).push({}); Eli Lilly and Company has signed an expanded licensing deal worth up to $1 billion with Chinese biotech company Innovent Biologics for their More...

By pharmanewsdaily On Saturday, May 9th, 2020

Lilly bags Retevmo FDA approval for RET-driven lung and thyroid cancers

Retevmo FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Retevmo (selpercatinib, 40mg and 80mg capsules) for the treatment of adults with metastatic More...

By pharmanewsdaily On Thursday, December 12th, 2019

Lilly launches LIBRETTO-431 clinical trial for selpercatinib in NSCLC

Eli Lilly and Company (Lilly) has initiated the phase 3 LIBRETTO-431 clinical trial to evaluate selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) in patients who are treatment-naïve. The More...